Literature DB >> 29693251

NOTCH4 regulates colorectal cancer proliferation, invasiveness, and determines clinical outcome of patients.

Zixi Zhang1,2, Xin Bu3, Jingyi Yang4, Shaojun Zhu5, Shuixiang He1, Jianyong Zheng6, Weizhong Wang6, Dake Chu1.   

Abstract

Notch signal has complex roles in human malignancies, which might be attributed to the diversity of Notch receptors. Here, we set out to identify the association of NOTCH4 with colorectal cancer (CRC). In the hospital-based study cohort, we investigated NOTCH4 mRNA levels in primary CRC, as well as its association with clinicopathologic characteristics. Besides, NOTCH4 cDNA and siRNA was transfected into colorectal cancer cell line to elucidate its impact on tumor cell proliferation and migration. Results revealed a statistically significant lower expression of NOTCH4 mRNA in tumor specimens compared with that in control. NOTCH4 level in CRC was found to be related to tumor differentiation, invasion, and node metastasis. Moreover, it was demonstrated that NOTCH4 mRNA level could be an independent prognostic factor for both disease-free and overall survival of CRC patients. Overexpression of NOTCH4 in CRC cell lines suppressed tumor cell proliferation, migration, and invasion, while induced apoptosis. In the opposite, the malignant behavior of CRC cells was enhanced by NOTCH4 knockdown. These results demonstrated for the first time that NOTCH4 expression was decreased in CRC, which could determine tumor proliferation, relapse, and prognosis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  NOTCH4; colorectal cancer; prognosis; proliferation; relapse

Mesh:

Substances:

Year:  2018        PMID: 29693251     DOI: 10.1002/jcp.26619

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Association between single nucleotide polymorphisms of NOTCH signaling pathway-related genes and the prognosis of NSCLC.

Authors:  Qiuping Xu; Danhua Lin; Xu Li; Rendong Xiao; Zhiqiang Liu; Weimin Xiong; Lin Cai; Fei He
Journal:  Cancer Manag Res       Date:  2019-07-24       Impact factor: 3.989

Review 2.  Research progress on O-GlcNAcylation in the occurrence, development, and treatment of colorectal cancer.

Authors:  Yao Liu; Fang-Xing Peng
Journal:  World J Gastrointest Surg       Date:  2021-02-27

3.  Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.

Authors:  Jiaochen Luan; Qijie Zhang; Lebin Song; Yichun Wang; Chengjian Ji; Rong Cong; Qitong Zheng; Zhenggang Xu; Jiadong Xia; Ninghong Song
Journal:  Transl Androl Urol       Date:  2021-03

Review 4.  Colorectal liver metastasis: molecular mechanism and interventional therapy.

Authors:  Hui Zhou; Zhongtao Liu; Yongxiang Wang; Xiaoyong Wen; Eric H Amador; Liqin Yuan; Xin Ran; Li Xiong; Yuping Ran; Wei Chen; Yu Wen
Journal:  Signal Transduct Target Ther       Date:  2022-03-04

5.  Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancer.

Authors:  Qi Zhao; Feng Wang; Yan-Xing Chen; Shifu Chen; Yi-Chen Yao; Zhao-Lei Zeng; Teng-Jia Jiang; Ying-Nan Wang; Chen-Yi Wu; Ying Jing; You-Sheng Huang; Jing Zhang; Zi-Xian Wang; Ming-Ming He; Heng-Ying Pu; Zong-Jiong Mai; Qi-Nian Wu; Renwen Long; Xiaoni Zhang; Tanxiao Huang; Mingyan Xu; Miao-Zheng Qiu; Hui-Yan Luo; Yu-Hong Li; Dong-Shen Zhang; Wei-Hua Jia; Gong Chen; Pei-Rong Ding; Li-Ren Li; Zheng-Hai Lu; Zhi-Zhong Pan; Rui-Hua Xu
Journal:  Nat Commun       Date:  2022-04-29       Impact factor: 17.694

6.  A comprehensive multi-omics analysis reveals molecular features associated with cancer via RNA cross-talks in the Notch signaling pathway.

Authors:  Li Guo; Sunjing Li; Xiaoqiang Yan; Lulu Shen; Daoliang Xia; Yiqi Xiong; Yuyang Dou; Lan Mi; Yujie Ren; Yangyang Xiang; Dekang Ren; Jun Wang; Tingming Liang
Journal:  Comput Struct Biotechnol J       Date:  2022-07-26       Impact factor: 6.155

7.  Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy.

Authors:  Junyu Long; Dongxu Wang; Xu Yang; Anqiang Wang; Yu Lin; Mingjun Zheng; Haohai Zhang; Xinting Sang; Hanping Wang; Ke Hu; Haitao Zhao
Journal:  BMC Med       Date:  2021-07-21       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.